Cancer

$400 Million Victory: Louisiana Jury Holds Major Insurer Accountable for Underpayment in Landmark Case Involving Cancer Patient Care

by

New Orleans, LA — A Louisiana civil court verdict has ordered the state’s premier health insurer, Blue Cross Blue Shield of Louisiana (BCBS), to compensate a surgical hospital over $400 million for a backlog of underpaid claims. This ruling comes as a significant breakthrough for healthcare providers in their ongoing struggle against powerful insurance firms over fair payment practices. The target of the litigation, St Charles Surgical Hospital, known for specializing in cancer treatments, accused BCBS of insufficiently compensating for 9,000 previously authorized procedures over a decade. According to hospital officials, the insurance giant either … Read more

Louisiana Jury Hits Major Insurer with $400M Verdict for Underpayment to Cancer Surgery Center

by

New Orleans, LA — In a significant legal setback for Blue Cross Blue Shield of Louisiana, a civil court jury has mandated the insurance giant to pay over $400 million for claims underpayments to a local surgery center focusing on cancer treatments. The verdict marks an unprecedented challenge to the practices of major health insurers in Louisiana, escalating concerns about the implications for medical claim settlements statewide. The court’s decision came after allegations surfaced that Blue Cross had either delayed, underpaid, or completely denied payment for approximately 9,000 approved procedures over a decade at St … Read more

Philadelphia Jury Awards $175 Million in Groundbreaking Roundup Cancer Case, Sparking Wave of New Trials Nationwide

by

Philadelphia – The first trial of the national Roundup litigation, a major event that could set the tone for upcoming cases, opened in Philadelphia, known for its active products liability docket. Attorney Thomas R. Kline, leading the trial and a finalist for The Legal Intelligencer’s Attorney of the Year, has emerged hopeful due to the strategic shifts and thorough examination of scientific evidence his team employed. Kline’s representation of 83-year-old Philadelphia resident Ernest Caranci, who suffers from non-Hodgkin’s lymphoma attributed to long-term Roundup usage, has been both professionally and personally impactful. The most striking moment … Read more

Another Chicago Jury Declines to Award Damages in Zantac Cancer Lawsuit, as California Trial Begins

by

Chicago, IL — A Cook County Circuit Court jury recently declared a mistrial in a lawsuit concerning the heartburn medication Zantac, marking the fourth such outcome in Chicago courts. These proceedings revolve around allegations that the manufacturer, Boehringer Ingelheim, failed to warn users that the drug could allegedly lead to cancer. This recent decision follows close on the heels of two other similar outcomes involving Zantac disagreements, with the notable instance last month when another jury reached a decision against GlaxoSmithKline, a different manufacturer of the same medication. The legal battles are far from confined … Read more